Reported Dec 24, 2024 · Announced
Astellas Pharma US, Inc. recalls Astellas Tacrolimus and Tacrolimus Extended-Release capsules due to Bottles may contain empty capsules.
Astellas Pharma US, Inc.
Risk not classifiedThe agency has not ranked the risk yet — treat the notice as a caution.What you should do
Stop using the product and follow the return or refund instructions in the firm's announcement.
Is this the product you have?
- Tacrolimus and Tacrolimus
- Extended-Release capsules BrandAstellas. Drugs
Why it was recalled
Bottles may contain empty capsules.
The agency has not ranked the risk yet — treat the notice as a caution.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Astellas Pharma US, Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.